BGI Genomics Co., Ltd (SHE: 300676), a leading genomics company based in China, has announced that its subsidiary, Heilongjiang BGI Longjiang Medical Laboratory Co., Ltd, has entered into a three-year cooperation agreement with the Health Commission of Heilongjiang Province. This agreement focuses on providing noninvasive prenatal genetic testing services for pregnant women within the province.
Starting from September 1, the initiative will offer free noninvasive prenatal genetic screening services to women residing in Heilongjiang who are between 12 to 22 (+6) weeks into their pregnancy.- Flcube.com
